(Hyp3,_-(2-thienyl)-Ala5,Tyr(Me)8-(R)-Arg9)-Bradykinin, a selective bradykinin B2 receptor agonist, has a longer plasma half-life than bradykinin, and transiently increases the blood-brain barrier (BBB) permeability to facilitate drug delivery to the central nervous system.